@article{977fe74cd83140f6ade8f686fb175369,
title = "Revolutionary Advances in Immunotherapy for Melanoma Are Coming into the Surgical Arena: Are We Ready?",
author = "Balch, {Charles M.}",
note = "Funding Information: Robert H.I. Andtbacka, MD, is acknowledged for his contributions in concept to the descriptive information about the genetically engineered oncolytic virus talimogene laherparepvec (T-VEC), and Gail Flores, PhD, is thanked for her literature review and editorial contributions to this introduction/editorial.",
year = "2018",
month = jul,
day = "1",
doi = "10.1245/s10434-018-6516-4",
language = "English (US)",
volume = "25",
pages = "1803--1806",
journal = "Annals of surgical oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "7",
}